{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:02Z","timestamp":1761630482623},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T00:00:00Z","timestamp":1206403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1038\/ncponc1105","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T17:04:11Z","timestamp":1206464651000},"page":"291-295","source":"Crossref","is-referenced-by-count":12,"title":["Five donors\u2013one recipient: modeling a mosaic of granulocytes, natural killer and T cells from cord-blood and third-party donors"],"prefix":"10.1038","volume":"5","author":[{"given":"Bj\u00f6rn","family":"Sch\u00f6ttker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Feuchtinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schumm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdwine","family":"Klinker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupert","family":"Handgretinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Einsele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Stuhler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,25]]},"reference":[{"key":"BFncponc1105_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/sj.bmt.1705676","volume":"39","author":"M Schumm","year":"2007","unstructured":"Schumm M et al. (2007) Flow cytometry with anti-HLA antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation. Bone Marrow Transplant 39: 767\u2013773","journal-title":"Bone Marrow Transplant"},{"key":"BFncponc1105_CR2","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1182\/blood-2003-09-3056","volume":"103","author":"G Rauser","year":"2004","unstructured":"Rauser G et al. (2004) Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood 103: 3565\u20133572","journal-title":"Blood"},{"key":"BFncponc1105_CR3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","volume":"87","author":"D Hoelzer","year":"1996","unstructured":"Hoelzer D et al. (1996) Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 87: 495\u2013508","journal-title":"Blood"},{"key":"BFncponc1105_CR4","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/cncr.22631","volume":"109","author":"OG Ottmann","year":"2007","unstructured":"Ottmann OG et al. (2007) Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ALL). Cancer 109: 2068\u20132076","journal-title":"Cancer"},{"key":"BFncponc1105_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1056\/NEJM199708073370602","volume":"337","author":"E Gluckmann","year":"1997","unstructured":"Gluckmann E et al. (1997) Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 337: 373\u2013381","journal-title":"N Engl J Med"},{"key":"BFncponc1105_CR6","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1056\/NEJM200106143442402","volume":"344","author":"MJ Laughlin","year":"2001","unstructured":"Laughlin MJ et al. (2001) Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344: 1815\u20131822","journal-title":"N Engl J Med"},{"key":"BFncponc1105_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/sj.bmt.1705467","volume":"38","author":"L Lekakis","year":"2006","unstructured":"Lekakis L et al. (2006) Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies. Bone Marrow Transplant 38: 421\u2013426","journal-title":"Bone Marrow Transplant"},{"key":"BFncponc1105_CR8","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1056\/NEJMoa041276","volume":"351","author":"MJ Laughlin","year":"2004","unstructured":"Laughlin MJ et al. (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351: 2265\u20132275","journal-title":"N Engl J Med"},{"key":"BFncponc1105_CR9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/sj.bmt.1704696","volume":"34","author":"C Ohwada","year":"2004","unstructured":"Ohwada C et al. (2004) Second cord blood transplantation (CBT) with reduced-intensity conditioning for graft failure after the first CBT for AML. Bone Marrow Transplant 34: 999\u20131000","journal-title":"Bone Marrow Transplant"},{"key":"BFncponc1105_CR10","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1097\/00029330-200609010-00016","volume":"119","author":"LP Xu","year":"2006","unstructured":"Xu LP et al. (2006) Successful second transplantation from haploidentical donor for graft failure following unrelated cord blood cell transplantation or mismatched related transplantation: 2 cases report. Chin Med J 119: 1489\u20131493","journal-title":"Chin Med J"},{"key":"BFncponc1105_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.bbmt.2006.08.041","volume":"13","author":"KK Ballen","year":"2007","unstructured":"Ballen KK et al. (2007) Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 13: 82\u201389","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFncponc1105_CR12","first-page":"640","volume":"91","author":"E Magro","year":"2006","unstructured":"Magro E et al. (2006) Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor. Hematologica 91: 640\u2013648","journal-title":"Hematologica"},{"key":"BFncponc1105_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.semcancer.2006.07.007","volume":"16","author":"L Ruggeri","year":"2006","unstructured":"Ruggeri L et al. (2006) Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. Semin Cancer Biol 16: 404\u2013411","journal-title":"Semin Cancer Biol"},{"key":"BFncponc1105_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/00002030-200003310-00007","volume":"14","author":"BM Anduze-Faris","year":"2000","unstructured":"Anduze-Faris BM et al. (2000) Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS 14: 517\u2013524","journal-title":"AIDS"},{"key":"BFncponc1105_CR15","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.4049\/jimmunol.166.8.4818","volume":"166","author":"A Moris","year":"2001","unstructured":"Moris A et al. (2001) Cutting edge: characterization of allorestricted and peptide-selective alloreactive T cells using HLA-tetramer selection. J Immunol 166: 4818\u20134821","journal-title":"J Immunol"},{"key":"BFncponc1105_CR16","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.4049\/jimmunol.175.3.1706","volume":"175","author":"AM Whitelegg","year":"2005","unstructured":"Whitelegg AM et al. (2005) Investigation of peptide involvement in T cell allorecognition using recombinant HLA class I multimers. J Immunol 175: 1706\u20131714","journal-title":"J Immunol"},{"key":"BFncponc1105_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1182\/blood-2002-02-0525","volume":"101","author":"PJ Amrolia","year":"2003","unstructured":"Amrolia PJ et al. (2003) Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity. Blood 101: 1007\u20131014","journal-title":"Blood"}],"container-title":["Nature Clinical Practice Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncponc1105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncponc1105","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncponc1105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:52:00Z","timestamp":1684443120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncponc1105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,25]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["BFncponc1105"],"URL":"https:\/\/doi.org\/10.1038\/ncponc1105","relation":{},"ISSN":["1743-4254","1743-4262"],"issn-type":[{"value":"1743-4254","type":"print"},{"value":"1743-4262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,25]]}}}